ChronoScale director granted 109,357 CHRN shares
ChronoScale Corp director Davis Scott G. reported a new stock award.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
ChronoScale Corp director Davis Scott G. reported a new stock award. He received 109,357 shares of common stock at no cost as a grant or award, increasing his direct holdings to 188,134 shares. The filing also notes 373 shares held indirectly through a 401(k) account.
The shares were acquired upon vesting of performance-based restricted stock units originally granted on November 5, 2025 under ChronoScale’s Amended and Restated 2014 Equity Incentive Plan and amended on May 14, 2026, highlighting that this is a compensation-related equity vesting rather than an open-market purchase or sale.
Insights
Director received a sizable equity vesting as routine compensation.
Davis Scott G., a director of ChronoScale Corp, acquired 109,357 shares of common stock via vesting of performance-based restricted stock units. The grant carried a reported price of $0.0000 per share, indicating a non-cash, compensation-related award rather than a market transaction.
The vesting stems from awards granted on November 5, 2025 under the Amended and Restated 2014 Equity Incentive Plan and amended on May 14, 2026. After this event, his direct holdings total 188,134 shares, with an additional 373 shares held indirectly via a 401(k) plan.
This pattern is typical of equity compensation structures that tie director pay to company performance. As there are no sales or option exercises reported and no derivative positions shown in this filing, the transaction mainly updates ownership records rather than signaling a change in the director’s market view of the stock.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 109,357 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- F1. The shares of common stock of ChronoScale Corporation (the "Issuer") were acquired upon vesting of performance-based restricted stock units granted to the Reporting Person on November 5, 2025 under the Issuer's Amended and Restated 2014 Equity Incentive Plan, which were amended on May 14, 2026.
Key Figures
Key Terms
performance-based restricted stock units financial
Amended and Restated 2014 Equity Incentive Plan financial
grant, award, or other acquisition financial
indirect ownership financial
401(k) financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did ChronoScale (CHRN) director Davis Scott G. report in this Form 4?
Was the ChronoScale (CHRN) Form 4 transaction a market purchase or sale?
What does the 401(k) entry mean in the ChronoScale (CHRN) Form 4 filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.